Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCGW.L Regulatory News (CGW)

  • There is currently no data for CGW

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

27 Apr 2016 12:35

RNS Number : 5324W
Chelverton Growth Trust PLC
27 April 2016
 

Chelverton Growth Trust PLC

Half Yearly Report

for the six months ended 29 February 2016

 

The Directors announce the unaudited Half Yearly Report for the period from 1 September 2015 to 29 February 2016.

 

Investment objective and policy

The Company's objective is to provide capital growth through investment in companies listed on the Official List and traded on the Alternative Investment Market ("AIM") with a market capitalisation at the time of investment of up to £50 million, which the Manager believes to be at a "point of change". The Company will invest in unquoted investments where it is believed that there is a likelihood of the shares becoming listed or traded on AIM or the investee company being sold. Its objective is to increase the net asset value per share at a higher rate than other quoted smaller company trusts and the MSCI Small Cap Index.

 

It is the Company's policy not to invest in any listed investment companies or listed investment trusts.

 

Investment strategy

Investments are selected for the portfolio only after extensive research which the Investment Manager believes to be key. The whole process through which equity must pass in order to be included in the portfolio is very rigorous. Only a security where the Investment Manager believes that the price will be significantly higher in the future will pass the selection process. The Investment Manager believes the key to successful stock selection is to identify the long-term value of a company's shares and to have the patience to hold the shares until that value is appreciated by other investors. Identifying long-term value involves detailed analysis of a company's earnings prospects over a five year time horizon.

 

The Company's Investment Manager is Chelverton Asset Management Limited, a specialist investment manager focusing exclusively on achieving returns for investors based on UK investment analysis of the highest quality. The founder and employee owners of Chelverton include experienced investment professionals with strong investment performance records who believe rigorous fundamental research allied to patience is the basis of long-term investment success.

 

Chairman's Report

Your Company has continued to make good progress in the first six months of the current year with the Net Asset Value ("NAV") per share rising by 4.1% from 54.95p to 57.21p. This compares favourably to our benchmark indices, the AIM All-share index and the MSCI Small Cap UK, which declined by 5.1% and 2.7% respectively. It is also pleasing to report that the share price increased by over 16% during the period from 42.5p to 49.5p.

 

Since the period end we have been able to increase the value of two of our unquoted investments, Transflex Vehicle Rental and Anaxsys Technology, rise substantially. Consequently, the NAV per share has increased further to 61.73p at the end of March 2016. In response, the share price has increased to 62p very close to the underlying NAV.

 

Although there is, as ever, political and economic uncertainty around the world, we remain in a low growth, low interest rate and low inflation environment. Corporate balance sheets and cash flows appear strong but real growth is increasingly difficult to achieve and maintain.

 

In the UK, the referendum on membership of the European Union will lead to increased uncertainty and consequent inaction by companies as they "sit on their hands" and await the outcome which is too close to call. If the electorate chooses to leave Europe it will potentially result in considerable short-term upheaval. However, in the main, the Board feels that the companies in which the Company is invested should produce improved trading performances in the short to medium term.

 

As stated previously, the Company is entering a phase of maturity and Shareholders should expect to see it become increasingly concentrated on a smaller number of investments. It is the Board's intention to continue with the annual tender offer and cancellation of shares, which may, in the short-term, result in a higher level of volatility in the NAV of the Company. In the longer term, we have faith in the businesses in which we are invested and expect long-term performance to be solid.

 

In line with the above policy, during the past six months further reductions have been made in the holding of IDOX and after the period end this investment was sold in its entirety. LPA was also reduced after a very strong share price performance. The holdings in Belgravium Technologies and La Salle Education were both increased in the period.

 

Following further growth of funds under management at Chelverton Asset Management, the Investment Managers of this fund, the valuation of this shareholding was increased again to reflect the company's underlying performance. Excellent progress at Transflex Vehicle Rental led to an increase in the valuation by 50% which is in line with the price placed on shares by the Board of the Company.

 

A new investment of £150,000 was made in Pedalling Forth Limited, trading as VeloVixen. The investment was part of a £500,000 development fundraising by the company. VeloVixen is a three-year old business which supplies women's cycling clothing and accessories via the internet. The funds will be used to raise the profile of the business and to provide working capital.

 

The proceeds received following the sale of the fund's largest investment Parmenion enabled us to eliminate borrowings and apply the cash to an offer for 24.99% of the outstanding shares in Chelverton Growth Trust.

 

This was the seventh tender offer. Valid applications were received from eligible Shareholders in respect of a total of 3,173,391 ordinary shares (representing approximately 37.33% of the Company's issued ordinary share capital at the record date). It successfully completed in March 2016 with the purchase by the Company of 24.99% of the issued share capital being 2,124,562 shares at 52.92p each. The tender price was calculated as being equal to 92.5% of the NAV per share on 29 February 2016.

 

These shares have subsequently been cancelled leaving a reduced share capital of 6,377,088 shares in issue. In the absence of any unexpected events, it is the Board's intention to repeat the process at the same time next year based on the net asset value per share calculated at 28 February 2017. It is interesting to note that following the seventh tender offer the number of shares acquired and cancelled is now 12,505,957 being a 66.2% reduction in the Company's original share capital.

 

Shareholders voted at the Annual General Meeting in December 2015 to flex the Investment Approach and to permit a reduction in the number of holdings. This change in policy recognises that future tender offers will make it likely that each year the number of investments will gradually reduce until at some point the Board will need to consider how to effect a final transfer of value to Shareholders.

 

Looking forward to the remainder of the financial year, the economic environment is going to be dominated by the EU Referendum in Britain. However, notwithstanding the uncertainty this will cause, the Board believes that the investment portfolio will continue to make good progress.

 

Kevin Allen

Chairman

 

27 April 2016

 

Interim management report

The important events that have occurred during the period under review and the key factors influencing the financial statements are set out in the Chairman's Report. The Board considers that the principal risks and uncertainties facing the Company remain the same as those disclosed in the Annual Report for the year ended 31 August 2015 on pages 12 and 13 and pages 49 to 51. These risks include, but are not limited to, market risk, discount volatility risk, regulatory risk, financial risk and liquidity risk.

 

Responsibility statement

The Directors are responsible for preparing the unaudited Half Yearly Report in accordance with applicable law and regulations. The Directors confirm that to the best of their knowledge:

 

The condensed set of financial statements for the six months to 29 February 2016, has been prepared in accordance with FRS 104 "Interim Financial Reporting", gives a fair view of the assets, liabilities, financial position and profit of the Company; and

This Half Yearly Report include a fair review of the information required by;

 

a) rule 4.2.7R of the Disclosure and Transparency Rules being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

 

b) rule 4.2.8R of the Disclosure and Transparency Rules, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the Company during that period; and any changes in the related party transactions described in the last Annual Report that could do so.

 

This Half Yearly Report was approved by the Board of Directors on 27 April 2016 and the above responsibility statement was signed on its behalf by Kevin Allen, Chairman.

 

Portfolio review

as at 29 February 2016

The Company's portfolio is set out below.

 

Investment

Sector

Valuation

% of

£'000

total

AIM traded

Alliance Pharma

Pharmaceuticals & Biotechnology

48

1.3

Acquisition of the manufacturing, sales and distribution rights to pharmaceutical products

Belgravium Technologies

Technology Hardware & Equipment

329

9.3

Software systems for warehousing and distribution

CEPS

Support Services

798

22.5

Production and supply of components for the footwear industry; personal protection equipment; production of printed lycra fabric; services to the direct mail industry and provision of "Clerk of Works"

IDOX

Software & Computer Services

204

5.7

Software company specialising in the development of products for document information management

Lombard Risk Management

Software & Computer Services

141

4.0

Lombard Risk is one of the world's leading providers of collateral management, liquidity analysis and regulatory compliance software to financial organisations

LPA Group

Electronic & Electrical Equipment

149

4.2

Design, manufacture and marketing of industrial electrical accessories

MTI Wireless Edge

Technology Hardware & Equipment

154

4.3

Developer and manufacturer of sophisticated antennas and antenna systems

Northbridge Industrial Services

Industrial Engineering

32

0.9

Provider of specialist industrial services

Petards Group

Support Services

184

5.2

Development, provision and maintenance of advance security systems and related services

Plutus Powergen

Flexible Energy Supply

350

9.9

Providers of management infrastructure and expertise to operate power plants and provide flexible electricity generation

Universe Group

Support Services

54

1.5

Provision of credit fraud prevention systems, loyalty systems and retail systems

Nasdaq Traded

One Horizon Group

Support Services

98

2.8

Provider of mobile satellite communications equipment and airtime

Unquoted

Airways Engineering

Support Services

Ordinary B Shares

-

-

Loan Stock

-

-

Commercial aviation maintenance

Anaxsys Technology

Healthcare Equipment & Services

13

0.4

A medical device company for patient monitoring and screening

Chelverton Asset Management Holdings

Support Services

130

3.7

Investment management, including providing services to Chelverton Growth Trust Plc

Closed Loop Recycling*

Support Services

Ordinary B Shares

-

-

Loan Stock

-

-

Operation of a plastic (PET and HDPE) recycling plant

La Salle Education Limited

Support Services

80

2.3

A UK based company dedicated to improving mathematics education.

Main Dental

Support Services

Ordinary B Shares

175

4.9

Loan Stock

-

-

Operator of dental surgeries

Security Research Group

Support Services

52

1.5

Leading provider of Local Authority residential property searches; provision of packaging solutions and technical surveillance countermeasure components

Transflex Vehicle Rental

Support Services

555

15.6

Light commercial vehicle rental

Portfolio valuation

3,546

100.0

* in administration

 

Portfolio holdings

29 February 2016

31 August 2015

Valuation

% of

Valuation

% of

Investment

£'000

total

£'000

total

CEPS

798

22.5

610

12.1

Transflex Vehicle Rental

555

15.6

555

11.0

Plutus Powergen

350

9.9

290

5.8

Belgravium Technologies

329

9.3

337

6.7

IDOX

204

5.7

164

3.3

Petards Group

184

5.2

169

3.4

Main Dental

175

4.9

175

3.5

MTI Wireless Edge

154

4.3

86

1.7

LPA Group

149

4.2

118

2.3

Lombard Risk Management

141

4.0

144

2.9

Chelverton Asset Management Holdings

130

3.7

120

2.4

One Horizon Group

98

2.8

134

2.7

La Salle Education Limited

80

2.3

25

0.5

Universe Group

54

1.5

65

1.3

Security Research Group

52

1.5

62

1.2

Alliance Pharma

48

1.3

56

1.1

Northbridge Industrial Services

32

0.9

60

1.2

Anaxsys Technology

13

0.4

13

0.3

Airways Engineering

-

-

-

-

Closed Loop Recycling Limited *

-

-

-

-

Parmenion Capital Partners LLP**

-

-

1,839

36.6

Total

3,546

100.0

5,022

100.0

* In Administration

** The Company retains an interest in a possible future bonus payment from Parmenion Capital Partners but at the date of this report the amount is not quantifiable.

 

Portfolio breakdown by sector and by index

 

Sector distribution

% of total

Support Services

60.0

Technology Hardware & Equipment

13.6

Flexible Energy Supply

9.9

Software & Computer Services

9.7

Electronic & Electrical Equipment

4.2

Pharmaceuticals & Biotechnology

1.3

Industrial Engineering

0.9

Healthcare Equipment & Services

0.4

 

Index distribution

% of total

AIM

68.8

Unquoted

28.4

Nasdaq OTC

2.8

 

Income statement (unaudited) for the six months to 29 February 2016

Six months to

Year to

Six months to

29 February 2016

31 August 2015

28 February 2015

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Gains on investments at fair value (note 4)

-

292

292

-

406

406

-

19

19

Income (note 2)

18

-

18

60

-

60

35

-

35

Investment management fee

(7)

(19)

(26)

(12)

(37)

(49)

(6)

(19)

(25)

Other expenses

(67)

(6)

(73)

(116)

(12)

(128)

(59)

(4)

(63)

Net return on ordinary activities before taxation

(56)

267

211

(68)

357

289

(30)

(4)

(34)

Taxation on ordinary activities

-

-

-

-

-

-

-

-

-

Net return on ordinary activities

(56)

267

211

(68)

357

289

(30)

(4)

(34)

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

pence

pence

pence

pence

pence

pence

pence

pence

pence

Return per Ordinary share*

 

(0.65)

 

3.14

 

2.49

 

(0.75)

 

3.96

 

3.21

 

(0.32)

 

(0.04)

 

(0.36)

 

All items in the above statement derive from continuing operations.

 

The revenue column of the Income Statement includes all income and expenses. The capital column accounts for the realised and unrealised profit or loss on investments and 75% of the management fee and finance costs charged to capital.

 

The total column of this statement is the Statement of Total Comprehensive Income of the Company prepared in accordance with Financial Reporting Standards ("FRS"). The supplementary revenue return and capital return columns are prepared in accordance with the Statement of Recommended Practice issued in November 2014 by the Association of Investment Companies ("AIC SORP").

 

\* The return per Ordinary share is based on 8,501,650 (31 August 2015: 9,019,251; 28 February 2015: 9,446,274) shares, being the weighted average number of shares in issue during the period.

 

Statement of changes in equity (unaudited) for the six months to 29 February 2016

Share

Capital

Share

premium

Special

Capital

redemption

Revenue

capital

account

reserve*

reserve

reserve

reserve

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Six months to 29 February 2016

1 September 2015

86 

2,674 

- 

913 

103 

896 

4,672 

Cancellation of share premium account

 

- 

 

(2,674)

2,674 

 

- 

 

- 

 

- 

 

- 

Costs relating to cancellation of share premium account

 

- 

- 

(19)

- 

- 

- 

(19)

Net return after taxation for the period

- 

- 

 - 

267 

- 

(56)

211 

29 February 2016

86 

- 

2,655 

1,180 

103 

840 

4,864 

 

 

Year to 31 August 2015

1 September 2014

96 

2,674 

556 

93 

1,435 

4,854 

Cost of shares purchased for cancellation under tender offer

 

(10)

 

- 

 

- 

 

10 

 

(446)

 

(446)

Net return after taxation for the period

- 

- 

357 

- 

(93)

264 

31 August 2015

86 

2,674 

913 

103 

896 

4,672 

 

 

Six months to 28 February 2015

1 September 2014

96 

2,674 

556 

93 

1,435 

4,854 

Net return after taxation for the period

- 

-

(4)

- 

(30)

(34)

28 February 2015

96 

2,674 

552 

93 

1,405 

4,820 

\* The special reserve was created by the cancellation of the share premium account by order of the High Court on 20 January 2016. The special reserve can be used for the purchase of the Company's Ordinary shares.

 

Statement of financial position (unaudited) as at 29 February 2016

As at 29 February 2016

£'000

As at 31 August 2015

£'000

As at 28 February 2015

£'000

Investments at fair value (note 4)

3,546 

5,022 

4,804 

Debtors

13 

2 

Cash at bank

1,328 

69 

454 

1,341 

78 

456 

Creditors

(23)

(28)

(40)

Short-term loan (note 5)

- 

(400)

(400)

(23)

(428)

(440)

Net current assets/(liabilities)

1,318 

(350)

16 

Net assets

4,864 

4,672 

4,820 

Share capital and reserves

Share capital

86

86

96

Share premium account

-

2,674

2,674

Special reserve

2,655

-

-

Capital reserve

1,180

913

552

Capital redemption reserve

103

103

93

Revenue reserve

840

896

1,405

Equity shareholders' funds

4,864

4,672

4,820

Net asset value per Ordinary share

(note 6)

 

57.21p

 

54.95p

 

51.03p

 

Statement of cash flows (unaudited)

for the six months to 29 February 2016

Six months to

Year to

Six months to

29 February

31 August

28 February

2016

2015

2015

£'000

£'000

£'000

Cash flows from operating activities

Net return

211 

289 

(34)

Adjustment for:

Net capital return

(267)

(357)

4

Expenses charged to capital

(25)

(48)

(23)

Interest paid

9 

15 

- 

(Decrease)/increase in creditors

(5)

7 

19 

(Increase)/decrease in prepayments and accrued income

(4)

1 

6 

Other

- 

(2)

- 

Cash used in operations

(81)

(95)

(28)

Cash flows from investing activities

Purchase of investments

(50)

(549)

(75)

Sales of investments

1,818 

960 

317 

Net cash inflow from investing activities

1,768 

411 

242 

Cash flows from financing activities

Cost of shares purchased for cancellation under tender offer

- 

(472)

- 

Cost of cancellation of share premium account

(19)

 - 

- 

New loan advanced

50 

200 

200 

Capital repayment of loan

 (450)

-

-

Interest paid

(9)

(15)

-

Net cash (used in)/from financing activities

(428)

(287)

200 

 Net increase in cash

1,259 

29 

414 

Cash at the beginning of the period

69 

40 

40 

Cash at the end of the period

1,328 

69 

454 

 

 

Notes to the financial statements

 

1 Accounting policies

 

a) Statement of compliance

The Company's Financial Statements for the period ended 29 February 2016 have been prepared under UK Generally Accepted Accounting Practice (UK GAAP) and the 2014 Statement of Recommended Practice, 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' ('the SORP') issued by the Association of Investment Trust Companies.

 

The Company has also adopted FRS 104, which applies to interim periods commencing on or after 1 January 2015. The transition to FRS 104 has had no impact on the previous reported financial position and financial performance. With the exception of this, the financial statements have been prepared in accordance with the accounting policies set out in the statutory accounts for the year ended 31 August 2015.

 

b) Financial information

The financial information contained in this report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The financial information for the period ended 29 February 2016 and 28 February 2015 have not been audited or reviewed by the Company's Auditor pursuant to the Auditing Practices Board guidance on such reviews. The information for the year to 31 August 2015 has been extracted from the latest published Annual Report and Financial Statements, which have been lodged with the Registrar of Companies, contained an unqualified auditors' report and did not contain a statement required under Section 498 (2) or (3) of the Companies Act 2006.

 

c) Going concern

The Company's assets consist mainly of equity shares in companies which, in most circumstances are realisable within a short timescale. The Directors believe that the Company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the accounts.

 

2 Income

 

 

Six months to

Year to

Six months to

 

29 February 2016

31 August 2015

28 February 2015

 

£'000

£'000

£'000

 

 

 

 

Income from investments

 

 

 

Income from LLP investments

15

35

22

UK net dividend income

3

21

9

Income from loan interest

-

4

4

 

Total income

18

60

35

 

 

3 Taxation

The tax charge for the six months to 29 February 2016 is nil (year to 31 August 2015: nil; six months to 28 February 2015: nil).

 

The Company has an effective tax rate of 0% for the year ending 31 August 2016. The estimated effective tax rate is 0% as investment gains are exempt from tax owing to the Company's status as an Investment Trust and there is expected to be an excess of management expenses over taxable income.

 

 

4 Investments

 

 

 

 

 

29 February

31 August

28 February

 

 

 

 

2016

2015

2015

 

AIM

Unquoted

NASDAQ

Total

Total

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

 

 

 

Opening book cost

2,990 

1,539 

166 

4,695 

4,595 

4,595 

Opening investment holding (losses)/gains

(891)

1,250 

(32)

327 

432 

432 

 

2,099 

2,789 

134 

5,022 

5,027 

5,027 

 

 

 

 

 

 

 

Movements in the period:

 

 

 

 

 

 

Purchases at cost

20 

30 

50 

549 

75 

Sales at cost

(14)

(115)

(129)

(449)

(181)

Gains on sales

22 

1,667 

1,689 

511 

136 

Movement in investment holding (losses)/gains

316 

(3,366)

(36)

(3,086)

(616)

(253)

 

 

 

 

 

 

 

Closing valuation

2,443 

1,005 

98 

3,546 

5,022 

4,804 

 

 

 

 

 

 

 

Closing book cost

2,996 

1,454 

166 

4,616 

4,695 

4,489 

 

Closing investment holding (losses)/gains

(553)

(449)

(68)

(1,070)

327

315 

 

 

 

 

 

 

 

Closing valuation

2,443 

1,005 

98 

3,546

5,022 

4,804 

 

 

 

 

 

 

 

Analysis of capital gains and losses

 

 

 

 

 

Realised gains on sales

22 

1,667 

-

1,689 

511 

136 

Movement in fair value of investments

338 

(1,699)

(36)

(1,397)

(105)

(117)

 

360 

(32)

(36)

292 

406 

19 

Fair value hierarchy

 

In accordance with FRS 102 and FRS 104 the Company must disclose the fair value hierarchy of financial instruments.

 

The fair value hierarchy consists of the following three classifications:

 

Classification A - Quoted prices in active markets for identical assets or liabilities.

 

Classification B - The price of a recent transaction for an identical asset, where quoted prices are unavailable.

 

Classification C Inputs for the asset or liability that are based on observable market data and unobservable market data, to estimate what the transaction price would have been on the measurement data in an arm's length exchange motivated by normal business considerations.

Details of the Company's financial instruments are shown in the Portfolio Review including financial instruments which fall into level C shown under the section heading "Unquoted". A summary reconciliation of the fair value movements of level C investments is shown in the table above. The realised gains on sales of £1,667,000 relates to the sale of Parmenion Capital Partners LLP on 12 January 2016.

Financial assets at fair value through profit or loss;

Classification A

Classification B

Classification C

Total

£'000

£'000

£'000

£'000

At 29 February 2016

Equity investments

2,541

-

1,005

3,546

Total

2,541

-

1,005

3,546

At 31 August 2015

Equity investments

2,233

-

2,789

5,022

Total

2,233

-

2,789

5,022

At 28 February 2015

Equity investments

2,477

-

2,327

4,804

Total

2,477

-

2,327

4,804

 

5 Short term loans

In November 2015 the Company borrowed £50,000 from Chelverton Asset Management Limited. The loans of £400,000 from Jarvis Investment Management Limited and £50,000 from Chelverton Asset Management Limited were repaid in full in January 2016.

 

6 Net asset value

The basic net asset value per Ordinary share is based on net assets of £4,864,000 (31 August 2015: £4,672,000; 28 February 2015: £4,820,000) and on 8,501,650 Ordinary shares (31 August 2015: 8,501,650; 28 February 2015: 9,446,274) being the number of Ordinary shares in issue at the period end.

 

7 Post balance sheet events

On 18 March 2016, pursuant to the Tender Offer, 2,124,562 Ordinary shares were repurchased for cancellation resulting in there being 6,377,088 Ordinary shares of 1p in issue.

 

8 Related party transactions

Under the terms of the agreement dated 28 June 2001, the Company has appointed Chelverton Asset Management Limited to be the Investment Manager. Mr Horner, a Director of the Company, is also a director of Chelverton Asset Management Limited and CEPS PLC, in which the Company holds an investment as set out above.

 

At 29 February 2016 there was £4,000 (31 August 2015: £4,000; 28 February 2015: £4,200) payable to the Investment Manager.

 

Mr Martin was appointed is the Chairman of Belgravium Technologies plc in which the Company holds an investment as set out above.

 

The three Directors also have individual holdings in Chelverton Asset Management Holdings, a company which has Mr Horner as a director and which the Company also has a direct holding. The Directors' holdings are detailed below.

 

Loan stock

Percentage of

Ordinary shares

Percentage of

held

Loan stock

held

Ordinary shares

held

held

£'000

%

£'000

%

Mr K Allen

-

-

1

1

Mr D Horner

925

86

56

56

Mr I Martin

-

-

2

2

 

The Company holds 2,000 shares in Chelverton Asset Management Limited representing 2% of the voting rights.

 

Directors and advisers

 

Directors

Registrars and Transfer Office

Kevin Allen (Chairman)

Share Registrars Limited

David Horner

Suite E, First Floor

Ian Martin

9 Lion and Lamb Yard

Farnham

Surrey GU9 7LL

Tel: 01252 821 390

Investment Manager

Auditors

Chelverton Asset Management Limited

Hazlewoods LLP

12B George Street

Windsor House

Bath BA1 2EH

Bayshill Road

Tel: 01225 483 030

Cheltenham GL50 3AT

Secretary and Registered Office

Custodian and Banker

ISCA Administration Limited

Jarvis Investment Management Limited

(appointed 21 December 2015)

78 Mount Ephraim

Suite 8, Bridge House

Royal Tunbridge Wells TN4 8BS

Courtenay Street

Tel: 01892 510 515

Newton Abbot

Devon TQ12 2QS

Tel: 01392 487 056

Email: cgw@iscaadmin.co.uk

 

Information about the Company can be obtained at the Investment Manager's website at www.chelvertonam.com.

Neither the contents of the Manager's website nor the contents of any website accessible from hyperlinks on this announcement (or any other website) is incorporated into, or forms part of this announcement

 

An investment company as defined under Section 833 of the Companies Act 2006.

REGISTERED IN ENGLAND No. 298951

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BBGDSXXDBGLR
Date   Source Headline
27th Nov 20233:42 pmRNSResult of Meeting
27th Nov 202310:30 amRNSSuspension - Chelverton Growth Trust plc
14th Nov 202312:36 pmRNSNet Asset Value(s)
1st Nov 20237:00 amRNSPublication of Circular and Notice of GM
9th Oct 20232:27 pmRNSNet Asset Value(s)
11th Sep 20234:41 pmRNSNet Asset Value(s)
25th Aug 20237:00 amRNSNet Asset Value(s)
4th Aug 202311:25 amRNSHolding(s) in Company
31st Jul 20239:59 amRNSHolding(s) in Company
31st Jul 20239:55 amRNSHolding(s) in Company
17th Jul 202311:02 amRNSNet Asset Value(s)
13th Jun 202310:28 amRNSNet Asset Value(s)
10th May 202311:09 amRNSNet Asset Value(s)
24th Apr 20237:00 amRNSHalf-year Report
6th Apr 20237:00 amRNSNet Asset Value(s)
20th Mar 20235:46 pmRNSDirector/PDMR Shareholding
3rd Mar 20235:03 pmRNSNet Asset Value(s)
6th Feb 20237:00 amRNSNet Asset Value(s)
16th Jan 20232:56 pmRNSHolding(s) in Company
16th Jan 202310:58 amRNSNet Asset Value(s)
15th Dec 20222:06 pmRNSResult of AGM
7th Dec 20221:11 pmRNSNet Asset Value(s)
10th Nov 20227:00 amRNSNet Asset Value(s)
9th Nov 20227:00 amRNSFinal Results
11th Oct 202210:55 amRNSNet Asset Value(s)
23rd Sep 20227:00 amRNSNet Asset Value(s)
5th Aug 202211:56 amRNSNet Asset Value(s)
6th Jul 202212:53 pmRNSNet Asset Value(s)
13th Jun 202212:40 pmRNSNet Asset Value(s)
16th May 20223:52 pmRNSNet Asset Value(s)
14th Apr 20223:12 pmRNSHalf-year Report
6th Apr 20227:00 amRNSNet Asset Value(s)
21st Mar 20227:00 amRNSNet Asset Value(s)
10th Feb 202211:43 amRNSNet Asset Value(s)
12th Jan 20225:52 pmRNSNet Asset Value(s)
11th Jan 20221:03 pmRNSResult of AGM
20th Dec 20213:11 pmRNSNet Asset Value(s)
16th Nov 20211:51 pmRNSFinal Results
9th Nov 20212:48 pmRNSNet Asset Value(s)
6th Oct 202110:03 amRNSNet Asset Value(s)
30th Sep 20215:32 pmRNSHolding(s) in Company
27th Sep 20212:38 pmRNSNet Asset Value(s)
12th Aug 202112:27 pmRNSNet Asset Value(s)
11th Aug 20212:52 pmRNSHolding(s) in Company
11th Aug 20212:48 pmRNSHolding(s) in Company
6th Jul 20214:42 pmRNSNet Asset Value(s)
5th Jul 20211:56 pmRNSHolding(s) in Company
10th Jun 20213:28 pmRNSHolding(s) in Company
9th Jun 202112:01 pmRNSDirector/PDMR Shareholding
9th Jun 202111:59 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.